Pheton Holdings Ltd Class A Ordinary Shares (PTHL) - Net Assets
Based on the latest financial reports, Pheton Holdings Ltd Class A Ordinary Shares (PTHL) has net assets worth $4.73 Million USD as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($5.11 Million) and total liabilities ($382.60K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Pheton Holdings Ltd Class A Ordinary Sha liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $4.73 Million |
| % of Total Assets | 92.52% |
| Annual Growth Rate | 86.41% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 925.22 |
Pheton Holdings Ltd Class A Ordinary Shares - Net Assets Trend (2021–2024)
This chart illustrates how Pheton Holdings Ltd Class A Ordinary Shares's net assets have evolved over time, based on quarterly financial data. Also explore Pheton Holdings Ltd Class A Ordinary Sha asset portfolio for the complete picture of this company's asset base.
Annual Net Assets for Pheton Holdings Ltd Class A Ordinary Shares (2021–2024)
The table below shows the annual net assets of Pheton Holdings Ltd Class A Ordinary Shares from 2021 to 2024. For live valuation and market cap data, see PTHL market cap overview.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $6.18 Million | +1919.35% |
| 2023-12-31 | $306.27K | -44.95% |
| 2022-12-31 | $556.32K | -41.71% |
| 2021-12-31 | $954.34K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Pheton Holdings Ltd Class A Ordinary Shares's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 174.5% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $1.43K | 0.02% |
| Other Comprehensive Income | $41.51K | 0.67% |
| Other Components | $6.66 Million | 107.76% |
| Total Equity | $6.18 Million | 100.00% |
Pheton Holdings Ltd Class A Ordinary Shares Competitors by Market Cap
The table below lists competitors of Pheton Holdings Ltd Class A Ordinary Shares ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Euro Menkul Kiymet Yatirim Ortakligi AS
IS:EUYO
|
$2.64 Million |
|
AdvancedAdvT Ltd
LSE:ADVT
|
$2.64 Million |
|
Oculus VisionTech Inc
V:OVT
|
$2.65 Million |
|
Shrenik Limited
NSE:SHRENIK
|
$2.65 Million |
|
Borqs Technologies Inc.
NASDAQ:BRQSF
|
$2.64 Million |
|
QVC Group Inc
NASDAQ:QVCGA
|
$2.63 Million |
|
SThree plc
LSE:STEM
|
$2.63 Million |
|
JEMTEC Inc
V:JTC
|
$2.63 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Pheton Holdings Ltd Class A Ordinary Shares's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 306,272 to 6,184,703, a change of 5,878,431 (1919.3%).
- Net loss of 661,000 reduced equity.
- New share issuances of 7,795,642 increased equity.
- Other comprehensive income decreased equity by 5,116.
- Other factors decreased equity by 1,251,095.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-661.00K | -10.69% |
| Share Issuances | $7.80 Million | +126.05% |
| Other Comprehensive Income | $-5.12K | -0.08% |
| Other Changes | $-1.25 Million | -20.23% |
| Total Change | $- | 1919.35% |
Book Value vs Market Value Analysis
This analysis compares Pheton Holdings Ltd Class A Ordinary Shares's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.58x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 4.28x to 0.58x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-12-31 | $0.07 | $0.28 | x |
| 2022-12-31 | $0.04 | $0.28 | x |
| 2023-12-31 | $0.02 | $0.28 | x |
| 2024-12-31 | $0.49 | $0.28 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Pheton Holdings Ltd Class A Ordinary Shares utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -10.69%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -147.48%
- • Asset Turnover: 0.07x
- • Equity Multiplier: 1.09x
- Recent ROE (-10.69%) is above the historical average (-13.55%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | 20.17% | 27.39% | 0.53x | 1.39x | $97.03K |
| 2022 | 15.10% | 12.35% | 0.48x | 2.52x | $28.35K |
| 2023 | -78.76% | -38.37% | 0.39x | 5.28x | $-271.84K |
| 2024 | -10.69% | -147.48% | 0.07x | 1.09x | $-1.28 Million |
Industry Comparison
This section compares Pheton Holdings Ltd Class A Ordinary Shares's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $2,555,245,291
- Average return on equity (ROE) among peers: -57.95%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Pheton Holdings Ltd Class A Ordinary Shares (PTHL) | $4.73 Million | 20.17% | 0.08x | $2.64 Million |
| Abbott Laboratories (ABT) | $24.08 Billion | 18.37% | 0.83x | $155.56 Billion |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-95.88 Million | 0.00% | 0.00x | $21.60 Million |
| Aethlon Medical Inc (AEMD) | $9.29 Million | -84.45% | 0.15x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $105.73 Million | -116.68% | 0.61x | $903.35K |
| Adapthealth Corp (AHCO) | $1.47 Billion | -46.29% | 2.07x | $1.39 Billion |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $15.99 Million |
| Allurion Technologies, Inc. (ALUR) | $-70.49 Million | 0.00% | 0.00x | $8.10 Million |
| Autonomix Medical, Inc. Common Stock (AMIX) | $644.00K | -309.01% | 0.34x | $4.22 Million |
| Artivion Inc (AORT) | $30.20 Million | 15.56% | 0.78x | $1.73 Billion |
| Apyx Medical Inc (APYX) | $22.89 Million | 2.69% | 0.23x | $125.55 Million |
About Pheton Holdings Ltd Class A Ordinary Shares
Pheton Holdings Ltd, a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company offers FTTPS, a treatment pl… Read more